Abstract: Despite its frequent use in equine clinical practice, scientific data on the use of acetaminophen in horses remain limited. Objective: To map and critically appraise the available evidence on the analgesic use, safety and pharmacokinetics of acetaminophen in horses. Methods: Structured scoping review. Methods: A comprehensive search was performed in accordance with the PRISMA Extension for Scoping Reviews using the terms '(paracetamol OR acetaminophen) AND (pain OR safety OR toxicosis OR pharmacokinetics) AND (horse OR pony OR donkey OR mule)' across Web of Science, Scopus, and PubMed from database inception to 27 July 2025. Experimental and clinical studies, reviews and case reports evaluating acetaminophen in equids were eligible. Publications without acetaminophen information about analgesia, safety or pharmacokinetics in horses were excluded. Each article was screened and charted according to study design, level of evidence (LoE) (methodological robustness) and thematic domain by two evaluators. Results: Of the initial 45 articles, 27 met eligibility criteria. Ten studies were classified as LoE 1, six as LoE 2, seven as LoE 3, and four as LoE 5. Based on study design and thematic domain, the included publications comprised four categorised as 'case reports', seven as 'narrative reviews', one as 'prospective comparative studies', 11 as 'pharmacokinetics', and four as 'pharmacokinetics and concentration-effect relationship'. Conclusions: Limited number of clinical studies and heterogeneity of available evidence. Conclusions: This review highlights the growing but still limited evidence on acetaminophen use in horses. While pharmacokinetic data are robust, clinical trials remain scarce and underpowered. Acetaminophen appears promising as part of multimodal analgesia, yet its efficacy as a sole agent and long-term safety require further investigation before widespread clinical adoption.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This research article systematically reviews existing scientific evidence on the use, safety, and pharmacokinetics of acetaminophen (paracetamol) in horses and other equids.
It highlights the current knowledge gaps and evaluates the quality of available studies to guide future research and clinical application.
Background and Objectives
Acetaminophen is frequently used as an analgesic in equine veterinary practice, but the scientific data supporting its use in horses remain limited.
The objective was to comprehensively map and critically assess evidence concerning three major themes in equids:
Analgesic use (effectiveness in pain relief)
Safety (toxicity and adverse effects)
Pharmacokinetics (how the drug is absorbed, distributed, metabolized, and eliminated)
Methods
The authors conducted a structured scoping review following PRISMA-ScR guidelines to ensure transparency and rigor.
They searched major databases (Web of Science, Scopus, PubMed) up to July 27, 2025, using specific search terms linking acetaminophen with equids and key concepts like pain, safety, toxicosis, and pharmacokinetics.
Inclusion criteria:
Studies involving horses, ponies, donkeys or mules
Research that assessed acetaminophen’s analgesic use, safety profile, or pharmacokinetics
Various study types included: experimental studies, clinical trials, reviews, and case reports
Excluded were studies lacking relevant data on acetaminophen use in equids for these specific domains.
Two reviewers independently screened and extracted data, classifying studies by:
Study design (e.g., case report, clinical trial, pharmacokinetics)
Level of evidence (LoE) indicating methodological quality, ranging from 1 (highest) to 5 (lowest)
Thematic content related to analgesia, safety, or pharmacokinetics
Results
Out of 45 initially identified articles, 27 met the eligibility criteria for inclusion.
Levels of evidence among included studies:
LoE 1 (highest quality): 10 studies
LoE 2: 6 studies
LoE 3: 7 studies
LoE 5 (lowest quality): 4 studies
Classification by study design and focus:
Case reports: 4
Narrative reviews: 7
Prospective comparative studies: 1
Pharmacokinetics-focused studies: 11
Pharmacokinetics plus concentration-effect (efficacy) relationship: 4
Key Findings
Pharmacokinetics:
The pharmacokinetic profile of acetaminophen in horses is relatively well characterized by multiple studies, providing robust data on how the drug behaves in equids.
This includes absorption rates, bioavailability, metabolism, half-life, and excretion.
Analgesic Use:
Clinical trials directly testing the analgesic efficacy of acetaminophen in horses are scarce (only one notable prospective comparative study).
Evidence suggests acetaminophen may be useful as part of multimodal analgesia (combined with other pain-relieving modalities), but its effectiveness as a sole analgesic agent remains unclear.
Safety:
Few studies and reports address the safety and potential toxicity of acetaminophen in horses.
Long-term safety data are lacking, which is important given the drug’s known adverse effects in other species at high doses or extended use.
Conclusions and Implications
The review reveals a growing body of research on acetaminophen in equids but still highlights significant gaps, particularly in clinical efficacy and safety data.
Pharmacokinetic studies provide a solid foundation for dosing considerations but do not substitute for clinical trial evidence on pain control effectiveness.
Before acetaminophen can be widely recommended as a single analgesic agent in equine veterinary practice, further well-designed clinical trials are needed to:
Confirm its analgesic potency when used alone
Assess safety during prolonged use
Compare its efficacy to other licensed analgesics
For now, acetaminophen may be considered as part of a multimodal pain management strategy in horses, but veterinarians should remain cautious given limited evidence.
Cite This Article
APA
Medina-Bautista F, Serrano-Rodríguez JM, Granados MDM.
(2026).
Analgesic use, safety and pharmacokinetics of acetaminophen in equids: A structured scoping review.
Equine Vet J.
https://doi.org/10.1002/evj.70315
Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology 2013;21(3):201–232.
Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS. COX‐3, a cyclooxygenase‐1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99(21):13926–13931.
Hernández‐Avalos I, Valverde A, Ibancovichi‐Camarillo JA, Sánchez‐Aparicio P, Recillas‐Morales S, Osorio‐Avalos J. Clinical evaluation of postoperative analgesia, cardiorespiratory parameters and changes in liver and renal function tests of paracetamol compared to meloxicam and carprofen in dogs undergoing ovariohysterectomy. PLoS One 2020;15(2):e0223697.
Högestätt ED, Jönsson BAG, Ermund A, Andersson DA, Björk H, Alexander JP. Conversion of acetaminophen to the bioactive N‐acylphenolamine AM404 via fatty acid amide hydrolase‐dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005;280(36):31405–31412.
Alloui A, Chassaing C, Schmidt J, Ardid D, Dubray C, Cloarec A. Paracetamol exerts a spinal, tropisetron‐reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol 2002;442(1–3):1–7.
Smith HS. Potential analgesic mechanisms of acetaminophen.. Pain Physician 2009;12(1):269–280.
de Kock SS, Mandy K, Martinovic ST, Jogi P, Guthrie AJ. A study of paracetamol, orthocetamol and metacetamol in horseracing in Southern Africa.. In: Houghton E, Ipek Keskin F, Wade JF, Yazicioglu N, editors. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey, 2008. Newmarket: R&W Publications (Newmarket) Ltd.; 2009. p. 363–369.
Mercer MA, Davis JL, McKenzie HC. Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia.. J Vet Intern Med 2023b;37(2):718–727.
Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D. PRISMA extension for scoping reviews (PRISMA‐ScR): checklist and explanation.. Ann Intern Med 2018;169(7):467–473.
Hydrocephalus Association. Research 101: Levels of evidence in hydrocephalus clinical research studies.. Hydroassoc.org. 2024 [cited 2024 Apr 27]. Available from: https://www.hydroassoc.org/research-101-levels-of-evidence-in-hydrocephalus-clinical-research-studies/.
Bruniges N, Milner P, Bardell D. The use of multimodal analgesia in the management of suspected compartment syndrome in a horse.. Equine Vet Educ 2017;31(7):354–362.
Tallon R, McMillan M, Ho N, Dunkel B. Presumed generalised seizure following caudal epidural administration of morphine and detomidine in a pony.. Equine Vet Educ 2020;33(10):372–375.
Foreman JH. A review of objective assessments of orthopaedic analgesic efficacy of non‐steroidal anti‐inflammatory drugs in horses.. Comp Exerc Physiol 2017;10(3):195–204.
De Laat MA, Sillence MN. A review of recent developments in the pharmacological prevention and treatment of endocrinopathic laminitis. Anim Prod Sci 2020;60:2081–2092.
Gold JR, Grubb T, Court MH, Villarino NF. Pharmacokinetics of acetaminophen after a single oral administration of 20 or 40 mg/kg to 7–9‐day‐old foals. Front Vet Sci 2023b;6(10):1198940.
Ishii H, Obara T, Kusano K, Kijima‐Suda I. Quantitative analysis of paracetamol, metacetamol, and orthocetamol in equine urine from racehorses in Japan using liquid chromatography–electrospray ionisation–tandem mass spectrometry. Drug Test Anal 2020;12(8):1196–1202.
Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006;79(4):371–378.
Bello S, Krogsbøll LT, Gruber J, Zhao ZJ, Fischer D, Hróbjartsson A. Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias. J Clin Epidemiol 2014;67(9):973–983.
Toutain PL, Lees P. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. J Vet Pharmacol Ther 2004;27(6):467–477.
Tarling MM, Toner CC, Withington PS, Baxter MK, Whelpton R, Goldhill DR. A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med 1997;23(3):256–260.
Mozaffari AA, Jarakanibayat S, Vosough D, Tajic J. The effect of the endotoxemia on the abomasal emptying rate in suckling lambs as shown by acetaminophen absorption test. Comp Clin Pathol 2017;27:283–287.
Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision‐making. Can J Hosp Pharm 2015;68(3):238–247.
Haddaway NR, Collins AM, Coughlin D, Kirk S. The role of Google scholar in evidence reviews and its applicability to grey literature searching. PLoS One 2015;10(9):e0138237.